相关实验视频

Updated: Jun 27, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.2K

转录组分析揭示了潜在的调控生物标志物和用于乳腺癌治疗的可重复使用药物

Most Shornale Akter1, Md Helal Uddin1, Sheikh Atikur Rahman1

  • 1Department of Biotechnology and Genetic Engineering, Islamic University, Kushtia, Bangladesh.

Cancer reports (Hoboken, N.J.)
|May 8, 2024
PubMed
概括

这项研究确定了关键的基因,微RNA和转录因子,涉及到乳腺癌 (BC) 进展. 它还表明了开发新的BC疗法的潜在药物化合物.

关键词:
生物标志物生物标志物乳腺癌 乳腺癌 乳腺癌核心蛋白质 - 核心蛋白质在分析中,分析.分子对接的分子对接.翻译学 翻译学 翻译学 翻译学

更多相关视频

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

10.5K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

696

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...